FibroGen Inc. (FGEN)
NASDAQ: FGEN
· Real-Time Price · USD
11.73
-0.20 (-1.68%)
At close: Oct 03, 2025, 3:59 PM
11.73
0.00%
After-hours: Oct 03, 2025, 04:10 PM EDT
-1.68% (1D)
| Bid | 11.31 |
| Market Cap | 47.43M |
| Revenue (ttm) | -72.84M |
| Net Income (ttm) | -2.07M |
| EPS (ttm) | -21.61 |
| PE Ratio (ttm) | -0.54 |
| Forward PE | -0.79 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 12.4 |
| Volume | 11,487 |
| Avg. Volume (20D) | 48,233 |
| Open | 11.71 |
| Previous Close | 11.93 |
| Day's Range | 11.64 - 12.06 |
| 52-Week Range | 4.50 - 21.95 |
| Beta | 0.77 |
| Ex-Dividend Date | n/a |
About FGEN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol FGEN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for FGEN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsFibroGen Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+19.07%
FibroGen shares are trading higher after the compa...
Unlock content with
Pro Subscription
1 month ago
+10.51%
FibroGen shares are trading higher after the company reported better-than-expected Q2 EPS results. Also, the company announced it will sell its China business to AstraZeneca for $210 million.
